Epidemiological, clinical, and laboratory factors associated with chronic kidney disease in Mexican HIV-infected patients.

J Bras Nefrol · 2019 · PMC6534026 · PMID 30010693

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a statistical trendno p-value reported

Treatment with saquinavir/ritonavir (OR 3.3, 95% CI 0.8-13.3, p = 0.09) and tenofovir/emtricitabine (OR 2.2, 95% CI 0.9-5.6, p = 0.09) showed a statistical trend for CKD risk defined by eGFR and albuminuria.

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.